Agah Ramtin's Insider Trades & SAST Disclosures
Agah Ramtin's most recent trade in RenovoRx Inc was a trade of 15,000 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on April 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Agah Ramtin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 15 Apr 2025 | 15,000 | 1,113,460 | - | 0.9 | 13,500 | Common Stock |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 254,542 | 254,542 | - | - | Stock Option | |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 11 Apr 2025 | 20,000 | 1,098,460 | - | 0.8 | 16,000 | Common Stock |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 09 Apr 2025 | 30,000 | 1,078,460 | - | 0.8 | 24,399 | Common Stock |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 08 Apr 2025 | 26,000 | 1,048,460 | - | 0.8 | 21,840 | Common Stock |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 47,460 | - | - | Common Stock | |
| RenovoRx Inc | Agah Ramtin | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrants | |
| RenovoRx Inc | Agah Ramtin | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 125,132 | 125,132 | - | - | Stock Option | |
| RenovoRx Inc | Agah Ramtin | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 28,424 | 28,424 | - | - | Stock Option | |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 65,000 | 65,000 | - | - | Employee Stock Option (right to buy) | |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2022 | 975,000 | 1,295 | - | 0 | Common Stock | |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2022 | 975,000 | 975,000 | - | 0 | Common Stock | |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 07 Jun 2022 | 5,182 | 6,477 | - | 1.9 | 10,001 | Common Stock |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 21,398 | 21,398 | - | - | Employee Stock Option (right to buy) | |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 52,203 | 52,203 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges